ENOB's free cash flow for Q3 2023 was $-3.31M. For the 2023 fiscal year, ENOB's free cash flow was decreased by $4.92M and operating cash flow was $-3.31M. See a summary of the company’s cash flow.

Cash Flow	TTM	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Operating Cash Flow	$ -12.56M	$ -15.73M	$ -20.61M	$ -10.46M	$ -8.51M	$ -4.34M
Investing Cash Flow	$ -23.63K	$ -5.16K	$ -48.89K	$ -184.46K	$ -716.67K	$ -575.73K
Financing Cash Flow	$ 4.34M	$ 4.25M	$ 32.60M	$ 7.20M	$ 6.02M	$ 16.71M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 23.11M	$ 9.17M	$ 20.66M	$ 8.70M	$ 12.28M	$ 15.60M
Income Tax Paid Supplemental Data	-	$ 34.00	$ 37.00	$ 0.00	$ 0.00	$ 0.00
Interest Paid Supplemental Data	$ 67.46K	$ 79.72K	$ 89.22K	$ 0.00	$ -43.00	$ 143.24K
Issuance Of Capital Stock	$ 3.66M	-	$ 33.07M	-	$ 0.00	$ 16.71M
Issuance Of Debt	-	-	$ 1.22M	$ 6.47M	$ 0.00	$ 0.00
Repayment Of Debt	$ -111.08K	-	$ -546.65K	$ -272.70K	$ 0.00	-
Free Cash Flow	$ -12.59M	$ -15.74M	$ -20.66M	$ -10.64M	$ -9.22M	$ -4.37M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Enochian Biosciences Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing